Internal Medicine, Rheumatology · Wichita Falls, TX
NPI
1649232810
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4412 Kell Blvd
Wichita Falls, TX, 76309
Phone (940) 692-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.5M
254,179 services
Medicare patients, 2024
700
Average age 71
Drug cost, 2024
$8.0M
10,346 prescriptions
Company payments, 2025
$53K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dianne M Cooper was code J3262 (injection, tocilizumab, 1 mg), 92,818 times for 21 patients. In total Dianne M Cooper billed 254,179 services in 56 codes, and Medicare paid $4.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 92,818 | 21 | $4.35 | $404K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 22,740 | 29 | $9.11 | $207K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 18,401 | 29 | $33.88 | $623K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 17,640 | 22 | $8.67 | $153K |
| J0897 Injection, denosumab, 1 mg | Office | 15,540 | 161 | $20.12 | $313K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 15,202 | 206 | $0.10 | $1,513 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 12,740 | 38 | $23.36 | $298K |
| J0490 Injection, belimumab, 10 mg | Office | 11,774 | 18 | $40.92 | $482K |
| J9312 Injection, rituximab, 10 mg | Office | 7,000 | 19 | $61.41 | $430K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 4,451 | 56 | $0.22 | $989 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 2,292 | 263 | $0.50 | $1,148 |
| 96372 Injection Administration | Office | 1,869 | 368 | $9.02 | $17K |
| 99214 Office E&M - Established | Office | 1,596 | 589 | $77.67 | $124K |
| 99213 Office E&M - Established | Office | 719 | 415 | $59.02 | $42K |
| 96375 Injection Administration | Office | 662 | 128 | $9.72 | $6,436 |
By year: 2022 $2.3M for 132,155 services; 2023 $3.6M for 197,806 services; 2024 $4.5M for 254,179 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dianne M Cooper prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 952 prescriptions and refills. In total Dianne M Cooper wrote 10,346 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 952 | 2,304 | 257 | $46K |
| Allopurinol Generic | 810 | 2,163 | 241 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 717 | 724 | 93 | $26K |
| Methotrexate Methotrexate Sodium | 580 | 1,343 | 156 | $18K |
| Gabapentin Generic | 392 | 795 | 94 | $10K |
| Celecoxib Generic | 373 | 809 | 111 | $17K |
| Prednisone Generic | 363 | 604 | 128 | $2,551 |
| Tramadol Hcl Generic | 261 | 269 | 68 | $2,259 |
| Enbrel Sureclick Etanercept | 238 | 294 | 34 | $2.2M |
| Leflunomide Generic | 187 | 435 | 59 | $12K |
| Duloxetine Hcl Generic | 180 | 449 | 39 | $4,282 |
| Azathioprine Generic | 174 | 440 | 57 | $7,291 |
| Folic Acid Generic | 169 | 407 | 46 | $2,140 |
| Famciclovir Generic | 169 | 307 | 39 | $38K |
| Mycophenolate Mofetil Generic | 168 | 420 | 55 | $9,433 |
Brand drugs: 1,482 claims; generic drugs: 8,853 claims; opioid claims: 1,460.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dianne M Cooper $53K ($53K in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $33K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 63 | $33K |
| GlaxoSmithKline, LLC. GSK | 23 | $18K |
| Abbvie Inc. ABBV | 28 | $422 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $382 |
| ANI Pharmaceuticals, Inc. ANIP | 19 | $341 |
| UCB, Inc. UCB.BR | 16 | $292 |
| Pfizer Inc. PFE | 17 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $104 |
| Genzyme Corporation SNY | 3 | $90.93 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $63.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.